Advances in treatment of methicillin-resistant Staphylococcus aureus infection in children
10.3760/cma.j.issn.2095-428X.2017.06.005
- VernacularTitle:儿童耐甲氧西林金黄色葡萄球菌感染治疗进展
- Author:
Yueqiang FU
;
Feng XU
- Keywords:
Methicillin-resistant Staphylococcus aureus;
Child;
Vancomycin;
Pneumonia;
Bacteremia
- From:
Chinese Journal of Applied Clinical Pediatrics
2017;32(6):416-419
- CountryChina
- Language:Chinese
-
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) infection can cause pneumonia,bacteremia,infective endocarditis and other diseases,seriously threat to the health of children.Pediatricians should discover the focus of infection.And the focus of infection should be removed or debrided in time.Vancomycin is an important drug for the treatment of MRSA infection,the use of Vancomycin need to ensure that the blood concentration is effective.Now,the advances in treatment of MRSA infection in children was mainly summarized.
